MUC1 in Colorectal Carcinoma: Association With Prognosis and Putative Anoikis‐Resistant Structures
APMIS · 2025-12 · 133 (12)
DOI: 10.1111/apm.70105 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, online erschienen am 02.12.2025. Verfasst von Taneli T Mattila und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Research Unit of Translational Medicine, University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Mucin-1, Colorectal Neoplasms, Anoikis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thelma Mäkikyrö Foundation.
Abstract (Originalsprache)
Mucin 1 (MUC1) is overexpressed in colorectal cancer (CRC), yet its prognostic value is controversial. In vitro, MUC1 promotes anoikis resistance. Putative anoikis‐resistant (AR) structures are clusters of carcinoma cells surviving without matrix contact, and are associated with adverse prognosis. We explored the prognostic role of MUC1 in CRC and its association with putative AR structures. We studied 118 patients with CRC, including 52 with nodal metastases. Immunohistochemical MUC1 expression was analyzed in primary tumors and nodal metastases by estimating the proportions of MUC1‐positive carcinoma cells within different subpopulations. In primary tumors, MUC1 expression was increased in most putative AR structure types, and abundant AR structures were associated with elevated MUC1. MUC1 in primary tumors was not prognostic. In nodal metastases, MUC1 levels correlated with those in primary tumors but were lower. High MUC1 levels in both primary tumors and metastases were associated with worse prognosis as compared with expression decreasing in nodal metastases. High MUC1 expression in nodal metastases was associated with synchronous distant metastasis and adverse prognosis. In conclusion, primary tumor MUC1 is not prognostic. In nodal metastases, high MUC1 associates with distant metastasis and poor outcomes. Putative AR structures show high MUC1 expression supporting its role in anoikis resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Research Unit of Translational Medicine, University of Oulu, Oulu, Finland.
- Department of Pathology, Oulu University Hospital and Medical Research Center Oulu, Oulu, Finland.
- Department of Molecular and Cellular Biology, University of California Davis, Davis, California, USA.
- Department of Surgery, Oulu University Hospital and Medical Research Center Oulu, Oulu, Finland.
- Department of Surgery, Research Unit of Surgery, Anesthesia and Intensive Care, University of Oulu, Oulu, Finland.
- Medical Informatics and Data Analysis Research Group, University of Oulu, Oulu, Finland.
ORCID-Profile: Tuomo J Karttunen
Förderung
- Thelma Mäkikyrö Foundation
Zitieren
APA
Mattila, T. T., Patankar, M., Väyrynen, J. P., Klintrup, K., Mäkelä, J., Tuomisto, A., Nieminen, P., Mäkinen, M. J., & Karttunen, T. J. (2025). MUC1 in Colorectal Carcinoma: Association With Prognosis and Putative Anoikis‐Resistant Structures. APMIS, 133(12). https://doi.org/10.1111/apm.70105
Vancouver
Mattila TT, Patankar M, Väyrynen JP, Klintrup K, Mäkelä J, Tuomisto A, et al. MUC1 in Colorectal Carcinoma: Association With Prognosis and Putative Anoikis‐Resistant Structures. APMIS. 2025;133(12). doi:10.1111/apm.70105
BibTeX
@article{Mattila2025,
author = {Mattila, Taneli T and Patankar, Madhura and Väyrynen, Juha P and Klintrup, Kai and Mäkelä, Jyrki and Tuomisto, Anne and Nieminen, Pentti and Mäkinen, Markus J and Karttunen, Tuomo J},
title = {MUC1 in Colorectal Carcinoma: Association With Prognosis and Putative Anoikis‐Resistant Structures},
journal = {APMIS},
year = {2025},
volume = {133},
number = {12},
doi = {10.1111/apm.70105}
}
EUVIMED